Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Neil E Fleshner
Defining a cohort of men who may not require repeat prostate biopsy based on PCA3 score and MRI: The dual negative effect.
J Urol. 2017 Nov 23;:
Extended Venous Thromboembolism Prophylaxis After Radical Cystectomy: A Call for Adherence to Current Guidelines.
J Urol. 2017 Nov 04;:
Preventing clinical progression and need for treatment in patients on active surveillance for prostate cancer.
Curr Opin Urol. 2017 Oct 11;:
Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes.
Urol Oncol. 2017 Sep 14;:
Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion.
Urol Oncol. 2017 Aug 03;:
Testosterone Responders to Continuous Androgen Deprivation Therapy Exhibit Considerable Variations in Testosterone Levels on Follow-Up: Implications for Clinical Practice.
J Urol. 2017 Jul 24;:
Metastatic renal cell carcinoma: Patterns and predictors of metastases-A contemporary population-based series.
Urol Oncol. 2017 Jul 17;:
JAMA Intern Med. 2017 Jul 17;:
Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.
Oncol Lett. 2017 Jul;14(1):390-396
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto